Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Cost of Revenue for 4 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 69.87% year-over-year to $1.7 billion, compared with a TTM value of $6.1 billion through Dec 2025, up 76.73%, and an annual FY2025 reading of $6.1 billion, up 216.01% over the prior year.
  • Cost of Revenue was $1.7 billion for Q4 2025 at GE HealthCare Technologies, down from $3.2 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $3.2 billion in Q3 2025 and bottomed at -$4.3 billion in Q4 2023.
  • Average Cost of Revenue over 4 years is $788.8 million, with a median of $800.5 million recorded in 2022.
  • The sharpest move saw Cost of Revenue crashed 3176.43% in 2023, then skyrocketed 909.62% in 2025.
  • Year by year, Cost of Revenue stood at $140.0 million in 2022, then tumbled by 3176.43% to -$4.3 billion in 2023, then surged by 123.43% to $1.0 billion in 2024, then soared by 69.87% to $1.7 billion in 2025.
  • Business Quant data shows Cost of Revenue for GEHC at $1.7 billion in Q4 2025, $3.2 billion in Q3 2025, and -$728.0 million in Q2 2025.